EyePoint Pharmaceuticals (EYPT) Stock Insights

EYPT price $0.38 +0.01 +3.91%

Ticker
EYPT
Price
$0.38
Change
+0.01 +3.91%
Market cap ?
$31.64M
Beta ?
1.68
Sector
Healthcare
Industry
Biotechnology

Fair value

EYPT fair value $10.36. Price $0.38. Price is 96% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.31M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.7). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 83.84M. Net debt -79.03M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare EYPT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.93—231.15K
2026-08-05-1.09-1.01507.00K443.00K
2026-05-06-0.99-0.79696.00K352.83K
2026-03-04-0.81-0.78620.00K994.46K
2025-11-05-0.85-0.77966.00K1.01M
2025-08-06-0.85-0.675.33M4.13M
2025-05-07-0.65-0.6524.45M6.82M
2025-03-05-0.64-0.5411.59M8.19M
2024-11-07-0.54-0.4810.52M10.56M
2024-08-07-0.58-0.559.48M9.59M
2024-05-08-0.55-0.3411.68M9.98M
2024-03-07-0.33-0.6014.03M8.90M
2023-11-01-0.33-0.6215.20M8.71M
2023-08-02-0.610.419.11M51.92M
2023-05-03-0.56-0.657.68M7.43M
2023-03-02-0.61-0.6310.50M10.40M
2022-11-02-0.49-0.7010.01M10.93M
2022-08-03-0.52-0.5711.56M10.86M
2022-05-04-0.52-0.509.29M9.89M
2022-03-03-0.59-0.5011.54M9.79M
2021-11-03-0.58-0.479.06M9.84M
2021-08-04-0.35-0.459.01M9.01M
2021-05-05-0.50-0.537.32M8.06M
2021-03-04-1.010.457.13M15.73M
2020-11-05-0.30-0.1015.70M4.08M
2020-08-05-1.00-1.104.12M4.12M
2020-05-06-1.10-1.007.49M6.81M
2020-03-05-0.90-1.208.63M10.36M
2019-11-07-1.40-1.402.51M2.34M
2019-08-07-1.10-1.307.21M7.87M
2019-05-08-1.60-1.302.01M1.41M
2019-03-14-1.20-1.402.44M2.85M
2018-11-06-1.90-1.30486.00K165.68K
2018-09-12-1.90-0.90715.00K127.74K
2018-05-08-1.50-1.30928.00K806.00K
2018-02-07-0.13-0.15933.00K1.07M
2017-11-07-1.50-1.50385.00K390.00K
2017-09-11-1.60-1.50701.00K656.25K
2017-05-04-1.50-1.50590.00K590.00K
2017-02-07-0.02-1.835.97M10.16M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-20Elston GeorgeBuy5.00K——
2026-08-20Elston GeorgeBuy64.95K——
2026-08-20Elston GeorgeSell64.95K——
2026-08-20Elston GeorgeSell5.00K——
2026-08-18Zaderej Karen L.Buy10.60K$4.9352.26K
2026-07-10Duker Jay S.Buy16.67K——
2026-07-10Duker Jay S.Sell8.06K$14.72118.63K
2026-07-10Duker Jay S.Sell16.67K——
2026-06-30Ribeiro RamiroSell2.44K$8.2620.13K
2026-06-30Ribeiro RamiroSell2.44K$8.2620.14K
2026-06-30Ribeiro RamiroBuy2.44K$8.2620.14K
2026-06-30Ribeiro RamiroSell2.44K$15.0036.55K
2026-06-30Ribeiro RamiroBuy2.44K$8.2620.13K
2026-06-30Ribeiro RamiroSell2.44K$15.0236.61K
2026-05-25Elston GeorgeBuy7.50K——
2026-05-25Elston GeorgeSell3.63K$12.9346.90K
2026-05-25Elston GeorgeSell7.50K——
2026-04-17Ribeiro RamiroSell2.44K$8.2620.13K
2026-04-17Ribeiro RamiroBuy2.44K$8.2620.13K
2026-04-17Ribeiro RamiroSell2.44K$15.0036.55K
2026-03-23Duker Jay S.Buy76.77K$13.111.01M
2026-03-23Duker Jay S.Buy97.50K$20.401.99M
2026-03-23Duker Jay S.Sell97.50K$20.401.99M
2026-03-23Duker Jay S.Buy52.50K$13.13689.33K
2026-03-23Duker Jay S.Sell52.50K$13.13689.33K
2026-03-23Duker Jay S.Sell76.77K$13.111.01M
2026-03-16Duker Jay S.Buy1.50K$13.1519.72K
2026-03-04Ribeiro RamiroSell2.44K$8.2620.14K
2026-03-04Ribeiro RamiroBuy2.44K$8.2620.14K
2026-03-04Ribeiro RamiroSell2.44K$17.8743.57K
2026-03-02Elston GeorgeSell5.00K——
2026-03-02Elston GeorgeBuy5.00K——
2026-02-17Ribeiro RamiroSell2.44K$8.2620.13K
2026-02-17Ribeiro RamiroBuy2.44K$8.2620.13K
2026-02-17Ribeiro RamiroSell2.44K$15.0036.55K
2026-01-06Lurker NancyBuy75.13K——
2026-01-06Lurker NancySell75.13K——
2026-01-06Duker Jay S.Buy20.79K——
2026-01-06Duker Jay S.Sell10.05K$16.86169.51K
2026-01-06Duker Jay S.Sell20.79K——
2026-01-06Elston GeorgeBuy15.29K——
2026-01-06Elston GeorgeSell4.49K$16.8675.65K
2026-01-06Elston GeorgeSell15.29K——
2026-01-05Ribeiro RamiroSell29.25K$8.26241.60K
2026-01-05Ribeiro RamiroBuy29.25K$8.26241.60K
2026-01-05Ribeiro RamiroSell42.54K$17.10727.32K
2026-01-05Duker Jay S.Buy30.00K——
2026-01-05Duker Jay S.Sell14.51K$17.43252.82K
2026-01-05Duker Jay S.Sell30.00K——
2026-01-05Elston GeorgeBuy15.00K——
2026-01-05Elston GeorgeSell4.40K$17.4376.74K
2026-01-05Elston GeorgeSell15.00K——
2026-01-05Lurker NancyBuy12.67K——
2026-01-05Lurker NancySell12.67K——
2026-01-03Ribeiro RamiroSell19.67K——
2026-01-03Ribeiro RamiroBuy19.67K——
2026-01-03Ribeiro RamiroSell6.37K$17.48111.40K
2026-01-03Duker Jay S.Sell65.00K——
2026-01-03Duker Jay S.Buy65.00K——
2026-01-03Duker Jay S.Sell23.45K$17.48409.85K
2026-01-03Elston GeorgeBuy19.67K——
2026-01-03Elston GeorgeSell6.32K$17.48110.54K
2026-01-03Elston GeorgeSell19.67K——
2026-01-02Ribeiro RamiroBuy171.40K$17.483.00M
2026-01-02Ribeiro RamiroBuy85.70K——
2026-01-02Duker Jay S.Buy331.00K$17.485.79M
2026-01-02Duker Jay S.Buy165.00K——
2026-01-02Elston GeorgeBuy126.00K$17.482.20M
2026-01-02Elston GeorgeBuy63.00K——
2026-01-02Zaderej Karen L.Buy40.00K$17.48699.20K
2026-01-02Sanders Reginald J.Buy40.00K$17.48699.20K
2026-01-02Lurker NancyBuy40.00K$17.48699.20K
2026-01-02Landis John B.Buy40.00K$17.48699.20K
2026-01-02Duty StuartBuy40.00K$17.48699.20K
2026-01-02Hassan FredBuy40.00K$17.48699.20K
2026-01-02DICICCO WENDY FBuy40.00K$17.48699.20K
2026-01-02ANDO GORANBuy41.50K$17.48725.42K
2025-12-19Elston GeorgeSell5.00K——
2025-12-19Elston GeorgeBuy5.00K——
2025-12-04Cormorant Asset Management, LPSell60.00K$15.70942.24K
2025-12-04Lurker NancySell9.30K$15.11140.48K
2025-11-28Lurker NancySell500$14.957.47K
2025-11-26Lurker NancySell200$14.952.99K
2025-11-11Ribeiro RamiroSell2.72K$11.6131.60K
2025-09-19Elston GeorgeSell20.00K——
2025-09-19Elston GeorgeBuy20.00K——
2025-07-11Zaderej Karen L.Buy2.00K——
2025-07-11Zaderej Karen L.Sell2.00K——
2025-07-10Lurker NancyBuy11.11K——
2025-07-10Lurker NancySell11.11K——
2025-07-10Duker Jay S.Buy16.67K——
2025-07-10Duker Jay S.Sell16.67K——
2025-07-10Duker Jay S.Sell7.69K$11.0685.03K
2025-07-02Lurker NancyBuy103.31K$3.26336.78K
2025-07-02Lurker NancyBuy31.16K$13.13409.20K
2025-07-02Lurker NancyBuy55.00K$10.13557.15K
2025-07-02Lurker NancySell103.31K$3.26336.78K
2025-07-02Lurker NancySell27.27K$20.40556.31K
2025-07-02Lurker NancySell55.00K$10.13557.15K
2025-07-02Lurker NancySell15.28K$9.11139.18K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 209, holders +5 vs prior quarter. Ownership 108.01%.

HolderSharesChangeChange %Value
MONTANOVA CAPITAL, LLC8.30M00.00%118.64M
BLACKROCK, INC.7.46M285.86K+3.98%106.72M
CORMORANT ASSET MANAGEMENT, LP7.00M-1.26M-15.31%100.10M
FEDERATED HERMES, INC.5.68M11.46K+0.20%81.24M
ADAGE CAPITAL PARTNERS GP, L.L.C.4.83M1.53M+46.30%69.04M
FRANKLIN TEMPLETON INC4.81M-241.52K-4.78%68.74M
COMMODORE CAPITAL LP4.60M1.77M+62.83%65.78M
JUPITER TOPCO LLC3.77M3.77MNew53.90M
VANGUARD CAPITAL MANAGEMENT LLC3.63M70.68K+1.99%51.91M
PARADIGM BIOCAPITAL ADVISORS LP2.89M-252.04K-8.02%41.33M
STATE STREET CORP2.36M260.34K+12.41%33.71M
GEODE CAPITAL MANAGEMENT, LLC2.06M78.72K+3.97%29.50M
ABERDEEN GROUP PLC2.01M270.42K+15.56%28.73M
PERCEPTIVE ADVISORS LLC2.00M2.00MNew28.60M
CITADEL ADVISORS LLC1.98M1.88M+1889.55%28.28M
BALYASNY ASSET MANAGEMENT L.P.1.81M373.62K+25.97%25.92M
PARKMAN HEALTHCARE PARTNERS LLC1.29M-66.64K-4.92%18.42M
EVENTIDE ASSET MANAGEMENT, LLC1.25M00.00%17.81M
TWO SIGMA INVESTMENTS, LP1.18M750.83K+174.48%16.89M
ESSEX WOODLANDS MANAGEMENT, INC.1.08M00.00%15.51M
ORBIMED ADVISORS LLC1.07M00.00%15.29M
5AM VENTURE MANAGEMENT, LLC1.05M00.00%15.02M
ROSALIND ADVISORS, INC.988.23K-48.51K-4.68%14.13M
VANGUARD PORTFOLIO MANAGEMENT LLC971.01K177.14K+22.31%13.89M
AMERIPRISE FINANCIAL INC848.41K425.15K+100.45%12.13M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

EyePoint Pharmaceuticals (EYPT) Stock Insights

EYPT$0.38+0.01 +3.91%

$31.64M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History